TRAF3 and melanoma: Furthermore, TRAF3 demonstrated carcinogenic properties in ACC (OS: n = 79, p < 0.001, Fig. 3O), LIHC (OS: n = 368, p = 0.010, Fig. 3P), THYM (OS: n = 118, p = 0.021, Fig. 3Q), and Uveal Melanoma (UVM) (OS: n = 80, p < 0.001, Fig. 3R).